Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540. Manufactured by: Macleods Pharmaceuticals Ltd. Sarigam, Valsad, Gujarat, India, NDC 33342-398-44.
Published June 18, 2025 · Recall initiated: May 29, 2025
Summary
FDA records drug Class III recall D-0470-2025, published June 18, 2025 and initiated May 29, 2025. Recalling firm: Macleods Pharmaceuticals Ltd; Status: Ongoing; Reported quantity: 1,344- 1000 count bottles; Lot: Lot #: MLF2401A, Exp 01/31/2026. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of a foreign substance: black hair found embedded in tablet.
What to do
Voluntary: Firm initiated · Letter
Get an email if LEVOTHYROXINE SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LEVOTHYROXINE SODIUM
- Manufacturer
- Macleods Pharmaceuticals Ltd
- Distributor
- Nationwide in the USA
- UPC
- 0333342393104
- Lot
- Lot #: MLF2401A, Exp 01/31/2026
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDALevothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only, Manufactured for: AccordSeptember 2, 2026
- FDALevothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Only, Manufactured for: AccordSeptember 2, 2026
- FDALevothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Only, Manufactured for: AccordSeptember 2, 2026
- FDALevothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: AccordSeptember 2, 2026
- FDACephalexin for Oral Suspension, USP, 125 mg per 5 mL, 200 mL (when mixed), Rx Only, Manufactured by: AlkemJune 18, 2025
- FDASulfamethoxazole and Trimethoprim Tablets, USP, 400 mg/80 mg, Rx Only, a) 100 Tablets per Bottle, NDC:June 18, 2025
Questions about this recall
Was Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540. Manufactured by: Macleods Pharmaceuticals Ltd. Sarigam, Valsad, Gujarat, India, NDC 33342-398-44. recalled?
Yes. FDA published recall D-0470-2025 on June 18, 2025. Reported hazard: Presence of a foreign substance: black hair found embedded in tablet.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LEVOTHYROXINE SODIUM. UPC: 0333342393104.